Clinical Trial Detail

NCT ID NCT01744652
Title Dasatinib and Crizotinib in Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Crizotinib + Dasatinib

Age Groups: adult

Additional content available in CKB BOOST